Skip to main content

Table 1 Patient characteristics

From: In vivo generated autologous plasmin assisted vitrectomy in young patients

Age

Gender/eye

Diagnosis

Inj-Op ınterval (day)

Treatment

No of attempts for PVD

Preop VA LogMAR

Postop VA LogMAR

Final status

Follow-up time (month)

Complication

39

M/L

Chronic RD

3

PPV, LE

3

2.00

0.70

Attached

23

None

12

F/L

Chronic RD

3

PPV

2

2.40

0.70

Attached

18

Re-RD

31

F/R

Chronic RD

3

PPV

3

2.40

1.00

Attached

14

ERM

17

M/R

Traumatic RD

3

PPV, LE

1

1.00

0.70

Attached

14

None

13

M/L

Traumatic RD

3

PPV, LE

3

0.70

0.20

Attached

26

None

12

F/L

OPM

3

PPV

4

1.30

0.30

Attached

14

None

39

M/R

Traumatic RD

3

PPV

1

1.80

0.70

Attached

15

None

39

F/L

VPT

3

PPV

2

1.30

0.10

Attached

26

None

10

M/R

MH

3

PPV

2

1.00

0.70

Attached

25

None

19

M/R

VPT

3

PPV, LE

2

2.00

0.40

Attached

23

None

29

F/L

Chronic RD

3

PPV

1

1.30

0.10

Attached

12

None

23

F/R

Chronic RD

3

PPV, LE

2

1.80

0.50

Attached

18

None

21

M/L

VPT

3

PPV, LE

2

1.00

1.00

Attached

25

Re-RD

21

F/L

OPM

3

PPV

2

1.30

0.70

Attached

14

None

19

M/L

VPT

3

PPV, LE

2

0.50

0.50

Attached

23

ERM, Re-RD

24

F/L

Chronic RD

3

PPV, LE

1

1.30

0.40

Attached

23

None

33

M/R

Chronic RD

3

PPV, LE

1

0.50

0.10

Attached

16

None

  1. PPV, pars plana vitrectomy; Inj-Op, ınjection-operation; PVD, Posterior vitreous detachment; VA, visual acuity; RD, retinal detachment; SiO, silicone oil; LE, lens extraction; MH, macular hole; OPM, optic pit maculopathy; VPT, vasoproliferative tumor